DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)

South Korea · Delayed Price · Currency is KRW

5,380.00

+170.00 (3.26%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Marketing Agency	3.35B	2.36B	1.12B	-	-
Marketing Agency Growth	41.98%	110.99%	-	-	-
Financial Industry	2.14B	966.08M	709.83M	-	-
Financial Industry Growth	121.57%	36.10%	-	-	-
Medicine	247.53B	214.88B	194.43B	-	-
Medicine Growth	15.20%	10.51%	-	-	-
Connection Adjustment	-3.74B	-2.52B	-1.27B	-	-
Pharmaceuticals	-	-	-	155.15B	139.22B
Pharmaceuticals Growth	-	-	-	11.45%	37.67%
Total	249.27B	215.69B	194.99B	155.15B	139.22B
Total Growth	15.57%	10.62%	25.68%	11.45%	37.67%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	244.60B	212.14B	194.99B	155.15B	139.22B
South Korea Growth	15.30%	8.80%	25.68%	11.45%	37.67%
Overseas	3.91B	2.92B	-	-	-
Overseas Growth	33.84%	-	-	-	-
Total	248.51B	215.06B	194.99B	155.15B	139.22B
Total Growth	15.55%	10.30%	25.68%	11.45%	37.67%

Source: S&P Global Market Intelligence.